Knowledges about beta-catenin regulation in glioma are recently increasing with R132H IDH1 mutation [39], FoxM1 [40], TRIM33 [41], HOXA13 [42] as examples of positive or negative regulators. Here, TRIM33 is linked to central nervous system cancer.